The literature consistently highlights the beneficial effects of various H3R antagonists and inverse agonists in addressing cognitive damage in AD, PD, anxiety, schizophrenia, depression, and sleep disorders [4,99,168,169,170]. This evidence concerns the gene HRH3 and depressive disorder.